Autopsy report · NCT05205785
Human Milk Oligosaccharides (HMOs) for Irritable Bowel Syndrome (IBS)
Cause of deathSlow enrollment
“Due to low enrollment, we have terminated this study”
Life of this trial
- Registered 1 year 3 months before it started.
- Ran for about 1 year 3 months before it stopped.
- 204 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- dsm-firmenich Switzerland AG
- Sponsor type
- Industry
- Conditions
- Irritable Bowel Syndrome; IBS - Irritable Bowel Syndrome
- Interventions
- Human Milk Oligosaccharide Mix; Placebo
- Participants
- 204
- Sites
- 1
- Countries
- Ireland
Trials that died the same way
- Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Enzalutamide and Docetaxel
“The study is terminated due to lower enrollment” - Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae.
“The study was terminated due to low enrollment” - Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease
“This study was terminated due to low participant enrollment.” - The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
“This study was prematurely terminated due to low enrollment” - Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE)
“Study was terminated due to low enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.